Clinical trials referenced in this document:
Documents that mention this clinical trial
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19
Funding for this research was provided by:
University Hospital of Reims, France (AOL 2020-COVID-19)
Received: 28 February 2022
Accepted: 9 July 2022
First Online: 2 August 2022
: This study was approved by the French ethics committee (Comité de Protection des Personnes du Nord-Ouest IV, number 2020-A01260-39, 30 April 2020; NCT04376840). Written informed consent was obtained for each patient. All methods have been performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.